My wife and I have taken on a new Friday night ritual.
And it just so happens to involve what promises to be a very lucrative trend for savvy tech investors.
Let me explain.
My wife and I have pretty demanding jobs, and we just don't have the energy to cook on Friday nights. So, for years, we'd usually order pizza to be delivered, occasionally switching things up with Chinese.
But a few months back, our mobile-centric daughters started talking up the joys of online ordering for food delivery. We decided to give it a try, and now we're hooked. One of the things we like most about this type of service is it gives us the ability to order from dozens of local restaurants.
And that's playing out in homes all over America as online and mobile orders shake up the U.S. restaurant industry – one currently valued at roughly $800 billion.
So, even a small portion of that massive market spells big profits for a firm that has the right kind of tech to hook hungry buyers as repeat clients.
With that in mind, today I'm going to show you a firm that is doing just that.
And I'll show you why this tech stock is set to double in less than two and a half years.
Check it out…
Getting Your "Grub" On
Now then, I've often written here highlighting this inescapable fact about the U.S. economy – every business today is a tech business.
Among other things, they all need access to e-commerce, digital payments, and mobile apps.
That last category is particularly tough for restaurants. They just don't have the time and talent to launch their own accurate online and mobile-ordering systems.
That's where GrubHub Inc. (Nasdaq: GRUB) comes into play. It offers users the chance to order their favorite foods from their desktops or handhelds, get an estimate of delivery time, find restaurants by cuisine type, and weigh user ratings.
In other words, it's a robust portal. And that's a big reason why industry experts say the portion of online restaurant orders could double in less than a decade.
Make no mistake – GrubHub is a seasoned leader that stands to offer investors at least a double in price appreciation.
Don't Miss: Four Stocks That Could Make Investors Millions in Election Years Like This One – Click Here Now
Now, let me show you why by running it through my five filters for building tech wealth.
Take a look…
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.